Big Pharma middlemen are jacking up prices by as much as 7,736%, per the FTC and MorePerfectUnion
Pharmacy benefit managers, or PBMs, are marking up the prices of specialty generic drugs and have made over $7 billion in excess revenue in the last 5 years.